Abstract: Cellular telephones capable of locally customizing viewer or user experience based on context are disclosed. A cellular telephone may collect information about viewers to modify its output. Mobile devices capable of locally customizing content are disclosed.

Abstract: Systems, methods, and other embodiments associated with wireless energy are described. In one embodiment, a method can comprise collecting an energy that is transmitted wirelessly to produce a collected energy. The method can also comprise supplying the collected energy to a device. Individual components within an electronic device can be physically decoupled from others, sending and receiving energy and data wirelessly. Such components can be sealed against air or fluid.

Abstract: The present invention provides compositions of CD180 targeting molecules coupled to heterologous antigens, and their use in treating and/or limiting disease.

Abstract: Systems, methods, and other embodiments associated with transitioning are described. In one embodiment, a method comprises analyzing at least one interface to produce an interface analysis result. The method also comprises causing a transformation of at least one constituent element based, at least in part, on the interface analysis result.

Abstract: An electronic system includes a rack assembly including a first rail and a second rail defining a first width therebetween and a chassis that supports electronic components and is insertable between the first rail and the second rail. The chassis includes a first side and a second side defining a second width therebetween that is less than the first width. The electronic system further includes a power connector coupled to the chassis and movable between a first position and a second position. The power connector and the second side define a third width when the power connector is in the first position. The power connector and the second side define a fourth width when the power connector is in the second position. The third width is greater than the first width and the fourth width is less than the first width.

Abstract: An electronic system includes a rack assembly including a first rail and a second rail defining a first width therebetween and a chassis that supports electronic components and is insertable between the first rail and the second rail. The chassis includes a first side and a second side defining a second width therebetween that is less than the first width. The electronic system further includes a power connector coupled to the chassis and movable between a first position and a second position. The power connector and the second side define a third width when the power connector is in the first position. The power connector and the second side define a fourth width when the power connector is in the second position. The third width is greater than the first width and the fourth width is less than the first width.

Abstract: Systems, methods, and other embodiments associated with wireless energy are described. In one embodiment, a method can comprise collecting an energy that is transmitted wirelessly to produce a collected energy. The method can also comprise supplying the collected energy to a device.

Abstract: The present limiting provides compositions of CD 180 targeting molecules coupled to heterologous antigens, and their use in treating and/or limiting disease.

Abstract: Disclosed is a method of detecting an anomalous propagation condition in a Radar system, comprising the steps of: subtracting returns received in a first receive period from returns received in a succeeding second receive period, and repeating this step for a plurality of receive periods; and if the step of subtracting gives a result in excess of a predetermined threshold in one of the plurality of receive periods, then registering this as a possible anomalous propagation condition.

Abstract: Systems, methods, and other embodiments associated with output production are described. One example system comprises an analysis component configured to analyze a data set to produce an evaluation result. The system also comprises a production component configured to produce a rendered output based, at least in part, on the evaluation result, where the rendered output is stored in a computer-readable medium.

Abstract: Systems, methods, and other embodiments associated with organism medical treatment are described. In one embodiment, a system can comprise a collection component configured to receive a medical control instruction. The medical control instruction can be based, at least in part, on an organism medical information set for an organism. The system can further comprise a regulation component configured to control administration of a treatment to the organism. The regulation component can control the administration of the treatment to the organism based, at least in part, on the medical control instruction.

Abstract: An electronic system includes a rack assembly including a first rail and a second rail defining a first width therebetween and a chassis that supports electronic components and is insertable between the first rail and the second rail. The chassis includes a first side and a second side defining a second width therebetween that is less than the first width. The electronic system further includes a power connector coupled to the chassis and movable between a first position and a second position. The power connector and the second side define a third width when the power connector is in the first position. The power connector and the second side define a fourth width when the power connector is in the second position. The third width is greater than the first width and the fourth width is less than the first width.

Abstract: A method for charging an electric vehicle includes steps of providing a charger station and providing an electric vehicle operable to navigate to a desired destination autonomously, the vehicle comprising a power receiver configured to mate with the charger station to provide charging to the electric vehicle. The method further includes steps of aligning, via autonomous operation of the electric vehicle, the charger station and the power receiver of the electric vehicle, so as mate the charger station and the power receiver, and initiating charging of the electric vehicle upon mating of the charger station and the power receiver.

Abstract: A redundant boost circuit configured to compensate for a voltage drop between a power supply and a plurality of loads is provided. The redundant boost circuit includes a first compensator module and a second compensator module. The first compensator module includes a first primary boost circuit and a first secondary boost circuit. The second compensator module includes a second primary boost circuit and a second secondary boost circuit. The first primary boost circuit and the second secondary boost circuit are electrically coupleable between the power supply and a first load. The second primary boost circuit and the first secondary boost circuit are electrically coupleable between the power supply and a second load.

Abstract: A controller for use in a line voltage drop compensation system is provided. The controller includes a processing device and a memory device coupled to the processing device. The controller is configured to determine a resistance of a power transmission line, the resistance of the power transmission line determined at least partially based on a plurality of characteristics of a load and the transmission line. The controller is also configured to generate a control signal to control an output voltage of a boost circuit, the output voltage determined at least partially based on the determined resistance of the power transmission line. The controller is further configured to transmit the control signal to the boost circuit to cause the boost circuit to generate an output voltage to compensate for the voltage drop.

Abstract: A charging system for charging an electric vehicle comprises an inductor-inductor-capacitor (LLC) battery charger that includes an isolation transformer having a transformer primary and a transformer secondary, the transformer primary included in an inductive charger station of the charging system and the transformer secondary included in an inductive power receiver of the charging system, with the inductive power receiver positioned on the electric vehicle. The LLC battery charger also includes a magnetizing inductor circuit element and a leakage inductor circuit element integrated into the isolation transformer on the transformer primary. The isolation transformer is constructed such that the transformer primary and the transformer secondary are separable from one another, with a selective engaging and disengaging of the transformer primary and the transformer secondary based on movement of the inductive power receiver on the electric vehicle relative to the inductive charger station.

Abstract: Systems, methods, and other embodiments associated with output production are described. One example system comprises an analysis component configured to analyze a data set to produce an evaluation result. The system also comprises a production component configured to produce a rendered output based, at least in part, on the evaluation result, where the rendered output is stored in a computer-readable medium.

Abstract: Bicyclic dihydropyrimidine-carboxamide compounds of formula I described herein inhibit Rho Kinase and may be used for the treatment of many disorders associated with ROCK enzymes mechanisms, such as pulmonary diseases including asthma, chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF) and pulmonary arterial hypertension (PAH).

Abstract: The present invention relates to pharmaceutical agents useful for therapy and/or prophylaxis in a mammal, and in particular to inhibitors of NF-?B-inducing kinase (NIK—also known as MAP3K14) useful for treating diseases such as cancer, inflammatory disorders, metabolic disorders and autoimmune disorders. The invention is also directed to pharmaceutical compositions comprising such compounds, to processes to prepare such compounds and compositions, and to the use of such compounds or pharmaceutical compositions for the prevention or treatment of diseases such as cancer, inflammatory disorders, metabolic disorders including obesity and diabetes, and autoimmune disorders.

Abstract: Bicyclic dihydropyrimidine-carboxamide compounds of formula I described herein inhibit Rho Kinase and may be useful in the treatment of many disorders associated with ROCK enzymes mechanisms, such as pulmonary diseases including asthma, chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF), and pulmonary arterial hypertension (PAH).